-
Something wrong with this record ?
Dynamics of caspase-3 activation and inhibition in embryonic micromasses evaluated by a photon-counting chemiluminescence approach
I. Chlastakova, M. Liskova, J. Kudelova, L. Dubska, K. Kleparnik, E. Matalova,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 1998-01-01 to 2018-12-31
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1998-01-01 to 2018-12-31
Public Health Database (ProQuest)
from 1998-01-01 to 2018-12-31
- MeSH
- Apoptosis drug effects MeSH
- Mice, Inbred Strains MeSH
- Caspase Inhibitors pharmacology MeSH
- Camptothecin pharmacology MeSH
- Caspase 3 metabolism physiology MeSH
- Cells, Cultured MeSH
- Luminescent Measurements methods MeSH
- Mice MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Caspases are key enzymatic components of the intracellular apoptotic machinery, and their role in mammalian systems is often studied using fluoromethylketone (FMK) inhibitors. Despite many advantages of such approach, efficiency of the inhibitor and membrane permeability speed are often questioned. This work therefore focuses on an exact evaluation of caspase-3 FMK inhibition dynamics in camptothecin-induced mesenchymal micromasses. Two parameters of caspase-3 FMK inhibitor were investigated: first, the stability of the inhibitory potential in the time course of cultivation and, simultaneously, the dynamics of caspase-3 FMK inhibition after camptothecin-induced apoptosis peak. A photon-counting chemiluminescence approach was applied for quantification of active caspase-3. The sensitivity of the photon-counting method allowed for evaluation of active caspase-3 concentration in femtogram amounts per cell. The inhibitor penetrated the cells within the first minute after its application, and the peak of caspase-3 started to decline to the blank level after 30 min. The inhibitory effect of the FMK inhibitor was unchanged during the entire 48 h of cultivation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024309
- 003
- CZ-PrNML
- 005
- 20170621072022.0
- 007
- ta
- 008
- 130703s2012 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11626-012-9542-8 $2 doi
- 035 __
- $a (PubMed)22976371
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Veselá, Ivana $u Institute of Animal Physiology and Genetics CAS, v.v.i., Brno, Czech Republic. $7 xx0214541
- 245 10
- $a Dynamics of caspase-3 activation and inhibition in embryonic micromasses evaluated by a photon-counting chemiluminescence approach / $c I. Chlastakova, M. Liskova, J. Kudelova, L. Dubska, K. Kleparnik, E. Matalova,
- 520 9_
- $a Caspases are key enzymatic components of the intracellular apoptotic machinery, and their role in mammalian systems is often studied using fluoromethylketone (FMK) inhibitors. Despite many advantages of such approach, efficiency of the inhibitor and membrane permeability speed are often questioned. This work therefore focuses on an exact evaluation of caspase-3 FMK inhibition dynamics in camptothecin-induced mesenchymal micromasses. Two parameters of caspase-3 FMK inhibitor were investigated: first, the stability of the inhibitory potential in the time course of cultivation and, simultaneously, the dynamics of caspase-3 FMK inhibition after camptothecin-induced apoptosis peak. A photon-counting chemiluminescence approach was applied for quantification of active caspase-3. The sensitivity of the photon-counting method allowed for evaluation of active caspase-3 concentration in femtogram amounts per cell. The inhibitor penetrated the cells within the first minute after its application, and the peak of caspase-3 started to decline to the blank level after 30 min. The inhibitory effect of the FMK inhibitor was unchanged during the entire 48 h of cultivation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a kamptothecin $x farmakologie $7 D002166
- 650 _2
- $a kaspasa 3 $x metabolismus $x fyziologie $7 D053148
- 650 _2
- $a inhibitory kaspas $x farmakologie $7 D061945
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a luminiscenční měření $x metody $7 D008163
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a inbrední kmeny myší $7 D008815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Liskova, M $u -
- 700 1_
- $a Kudelova, J $u -
- 700 1_
- $a Dubska, L $u -
- 700 1_
- $a Kleparnik, K $u -
- 700 1_
- $a Matalova, E $u -
- 773 0_
- $w MED00005672 $t In vitro cellular & developmental biology. Animal $x 1543-706X $g Roč. 48, č. 9 (2012), s. 545-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22976371 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20170621072441 $b ABA008
- 999 __
- $a ok $b bmc $g 987989 $s 822689
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 48 $c 9 $d 545-9 $i 1543-706X $m In vitro cellular & developmental biology. Animal $n In Vitro Cell Dev Biol Anim $x MED00005672
- LZP __
- $a Pubmed-20130703